EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plasma proteomic analysis identifies proteins and pathways related to Alzheimer's risk

Yen-Ning Huang, Shiwei Liu, Tamina Park, Soumilee Chaudhuri, Lindsey A Kuchenbecker, Minerva M Carrasquillo, Nilüfer Ertekin-Taner, Paula J Bice, Henrik Zetterberg, Kaj Blennow, Kristen Russ, Jeffrey L Dage und 15 weitere

Alzheimer's & Dementia · 2025-08 · 21 (8)

DOI: 10.1002/alz.70579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 14.08.2025. Verfasst von Yen-Ning Huang und 26 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Proteomics, Blood Proteins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION We investigated associations of plasma proteins with blood‐based amyloid/tau/neurodegeneration/inflammation (A/T/N/I) biomarkers for Alzheimer's disease (AD). METHODS Plasma proteomics and clinical data from the Indiana AD Research Center ( N = 498) were used. Association analysis of plasma proteins with blood A/T/N/I biomarkers as well as diagnosis was performed, followed by replication in an independent cohort ( N = 323), network analysis, pathway enrichment, and machine learning classification to identify proteins and pathways related to AD risk. RESULTS We identified 35 proteins associated with AD, 20 of which were replicated in the independent cohort. We identified 150, 448, and 219 proteins associated with T/N/I biomarkers, respectively, revealing biomarker‐specific pathways. Network analysis identified two modules associated with T/N/I biomarkers, preserved in cerebrospinal fluid (CSF), and their enriched pathways. The classification model of proteins effectively differentiated AD (area under the curve [AUC] = 0.930). CONCLUSION Our findings suggest dysregulated plasma proteins and pathways in AD, enhancing our understanding of molecular mechanisms and diagnostic strategies for AD. Highlights Plasma proteins were identified as being associated with Alzheimer's disease (AD) and plasma biomarkers. The identified proteins were replicated in both plasma and cerebrospinal fluid (CSF) proteomics. The identified proteins were associated with AD biomarker‐specific pathways. The identified proteins improved the performance of the AD classification. Protein network analysis identified network modules and their enriched pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseProteomicsBlood ProteinsHumansBiomarkersMaleFemaleAgedCohort StudiesMachine LearningAmyloid beta-Peptidestau Proteins

Stichwörter der Autor:innen

Alzheimer's diseaseSomaScanamyloidbiomarkerinflammationmachine learningnetwork analysisneurodegenerationplasmaproteomicstau

Substanzen

BiomarkersBlood ProteinsAmyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
  • Center for Clinical and Translational Science, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.

Förderung

  • NIA NIH HHS
  • NIH HHS
  • Swedish Research Council
  • Swedish State Support for Clinical Research
  • NIA
  • NLM NIH HHS
  • ADNI Health Enhancement Scientific Program, subaward of NIA
  • CLEAR-AD

Zitieren

APA

Huang, Y. N., Liu, S., Park, T., Chaudhuri, S., Kuchenbecker, L. A., Carrasquillo, M. M., Ertekin-Taner, N., Bice, P. J., Zetterberg, H., Blennow, K., Russ, K., Dage, J. L., Nudelman, K. N. H., Cruchaga, C., Brosch, J. R., Farlow, M. R., Clark, D. G., Mathew, S., Unverzagt, F., …, & Nho, K. (2025). Plasma proteomic analysis identifies proteins and pathways related to Alzheimer's risk. Alzheimer's & Dementia, 21(8). https://doi.org/10.1002/alz.70579

Vancouver

Huang YN, Liu S, Park T, Chaudhuri S, Kuchenbecker LA, Carrasquillo MM, et al. Plasma proteomic analysis identifies proteins and pathways related to Alzheimer's risk. Alzheimer's & Dementia. 2025;21(8). doi:10.1002/alz.70579

BibTeX
@article{Huang2025,
  author = {Huang, Yen-Ning and Liu, Shiwei and Park, Tamina and Chaudhuri, Soumilee and Kuchenbecker, Lindsey A and Carrasquillo, Minerva M and Ertekin-Taner, Nilüfer and Bice, Paula J and Zetterberg, Henrik and Blennow, Kaj and Russ, Kristen and Dage, Jeffrey L and Nudelman, Kelly N H and Cruchaga, Carlos and Brosch, Jared R and Farlow, Martin R and Clark, David G and Mathew, Sunu and Unverzagt, Frederick and Gao, Sujuan and Wang, Sophia and Apostolova, Liana G and Wilcock, Donna M and Foroud, Tatiana and Risacher, Shannon L and Saykin, Andrew J and Nho, Kwangsik},
  title = {Plasma proteomic analysis identifies proteins and pathways related to Alzheimer's risk},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {8},
  doi = {10.1002/alz.70579}
}
Kostenlos starten →